Cancer Research SABCS  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scanlan, M. J.
Right arrow Articles by Old, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scanlan, M. J.
Right arrow Articles by Old, L. J.
[Cancer Research 62, 4041-4047, July 15, 2002]
© 2002 American Association for Cancer Research


Immunology

Cancer-related Serological Recognition of Human Colon Cancer

Identification of Potential Diagnostic and Immunotherapeutic Targets1

Matthew J. Scanlan2, Sydney Welt, Claudia M. Gordon, Yao-Tseng Chen, Ali O. Gure, Elisabeth Stockert, Achim A. Jungbluth, Gerd Ritter, Dirk Jäger, Elke Jäger, Alexander Knuth and Lloyd J. Old

Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [M. J. S., S. W., C. M. G., Y-T. C., A. O. G., E. S., A. A. J., G. R., L. J. O.]; Weill Medical College of Cornell University, Department of Pathology, New York, New York 10021 [Y-T. C., D. J.]; and II.Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, 60488 Frankfurt, Germany [D. J., E. J., A. K.]

Monitoring human antibody recognition of tumor antigens could have potential diagnostic and prognosticsignificance. Serological analysis of recombinant cDNA expression libraries of human cancer has identified a number of immunogenic tumor antigens. To identify colon cancer antigens associated with a cancer-related serum IgG response, serum samples from 74 patients with colon cancer and 75 normal blood donors were screened for antibody reactivity to 77 serologically defined tumor antigens. The following 13 antigens reacted exclusively with sera from the colon cancer patients and not with sera from normal blood donors: p53, MAGEA3, SSX2, NY-ESO-1, HDAC5, MBD2, TRIP4, NY-CO-45, KNSL6, HIP1R, Seb4D, KIAA1416, and LMNA. Serum samples from 34 of 74 (46%) colon cancer patients detected 1 or more of these 13 antigens. Fifty-three of 74 colon cancer patients were of known clinicopathological stage. Analysis of antibody frequency showed that 5 of 7 (71%) stage I colon cancer patients, 4 of 11 (36%) stage II patients, 2 of 14 (14%) stage III patients, and 11 of 21 (52%) stage IV patients had serum IgG antibody that reacted with 1 or more of the 13 antigens. The mRNA expression patterns of 8 of these 13 antigens were altered in cancer. Three of the 13 antigens were cancer/testis antigens (MAGEA3, SSX2, and NY-ESO-1), which are expressed exclusively in normal gametogenic tissues and aberrantly expressed in a broad range of cancer types. Quantitative real-time reverse transcription-PCR showed that the mRNA expression levels of 2 antigens, HDAC5 and Seb4B, were down-regulated in colon cancer, 2 other antigens, KNSL6 and KIAA1416, were up-regulated, and another antigen, NY-CO-45, showed a variable level of mRNA expression in colon cancer. With regard to KNSL6 mRNA expression, only trace levels were detected in 15 different normal tissues with the exception of testis, which showed a high level of KNSL6 mRNA expression. In contrast, 9 of 9 colon cancer specimens showed overexpression of KNSL6 mRNA, ranging from 5 to 44 times the level detected in normal colon tissue, indicating that this antigen could also be a valuable therapeutic target.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. De, R. Cipriano, M. W. Jackson, and G. R. Stark
Overexpression of Kinesins Mediates Docetaxel Resistance in Breast Cancer Cells
Cancer Res., October 15, 2009; 69(20): 8035 - 8042.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
I. Babel, R. Barderas, R. Diaz-Uriarte, J. L. Martinez-Torrecuadrada, M. Sanchez-Carbayo, and J. I. Casal
Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays
Mol. Cell. Proteomics, October 1, 2009; 8(10): 2382 - 2395.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Ran, H. Hu, Z. Zhou, L. Yu, L. Sun, J. Pan, J. Liu, and Z. Yang
Profiling Tumor-Associated Autoantibodies for the Detection of Colon Cancer
Clin. Cancer Res., May 1, 2008; 14(9): 2696 - 2700.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Dokmanovic, G. Perez, W. Xu, L. Ngo, C. Clarke, R. B. Parmigiani, and P. A. Marks
Histone deacetylase inhibitors selectively suppress expression of HDAC7
Mol. Cancer Ther., September 1, 2007; 6(9): 2525 - 2534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. R. Pollack
A Perspective on DNA Microarrays in Pathology Research and Practice
Am. J. Pathol., August 1, 2007; 171(2): 375 - 385.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Caron, G. Choquet-Kastylevsky, and R. Joubert-Caron
Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery
Mol. Cell. Proteomics, July 1, 2007; 6(7): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Lu, X. Wang, Z.-F. Chen, D.-F. Sun, X.-Q. Tian, and J.-Y. Fang
Inhibition of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells
J. Biol. Chem., April 20, 2007; 282(16): 12249 - 12259.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan
Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1745 - 1759.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Abdul-Rasool, S H Kidson, E Panieri, D Dent, K Pillay, and G S Hanekom
An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.
J. Clin. Pathol., March 1, 2006; 59(3): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Erkanli, D. D. Taylor, D. Dean, F. Eksir, D. Egger, J. Geyer, B. H. Nelson, B. Stone, H. A. Fritsche, and R. B.S. Roden
Application of Bayesian Modeling of Autologous Antibody Responses against Ovarian Tumor-Associated Antigens to Cancer Detection
Cancer Res., February 1, 2006; 66(3): 1792 - 1798.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Chatterjee, S. Mohapatra, A. Ionan, G. Bawa, R. Ali-Fehmi, X. Wang, J. Nowak, B. Ye, F. A. Nahhas, K. Lu, et al.
Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays
Cancer Res., January 15, 2006; 66(2): 1181 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. V. Bradley, K. I. Oravecz-Wilson, G. Bougeard, I. Mizukami, L. Li, A. J. Munaco, A. Sreekumar, M. N. Corradetti, A. M. Chinnaiyan, M. G. Sanda, et al.
Serum Antibodies to Huntingtin Interacting Protein-1: A New Blood Test for Prostate Cancer
Cancer Res., May 15, 2005; 65(10): 4126 - 4133.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Li, Y.-H. Yuan, Y. Han, Y.-X. Liu, L. Yan, Y. Wang, and J. Gu
Expression Profile of Cancer-Testis Genes in 121 Human Colorectal Cancer Tissue and Adjacent Normal Tissue
Clin. Cancer Res., March 1, 2005; 11(5): 1809 - 1814.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. Ludewig, P. Krebs, H. Metters, J. Tatzel, O. Tureci, and U. Sahin
Molecular Characterization of Virus-induced Autoantibody Responses
J. Exp. Med., September 7, 2004; 200(5): 637 - 646.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. S. Hyun, D. S. Rao, D. Saint-Dic, L. E. Michael, P. D. Kumar, S. V. Bradley, I. F. Mizukami, K. I. Oravecz-Wilson, and T. S. Ross
HIP1 and HIP1r Stabilize Receptor Tyrosine Kinases and Bind 3-Phosphoinositides via Epsin N-terminal Homology Domains
J. Biol. Chem., April 2, 2004; 279(14): 14294 - 14306.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. M. Campbell, V. Bovenzi, and M. Szyf
Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo
Carcinogenesis, April 1, 2004; 25(4): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Bellucci, C. J. Wu, S. Chiaretti, E. Weller, F. E. Davies, E. P. Alyea, G. Dranoff, K. C. Anderson, N. C. Munshi, and J. Ritz
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens
Blood, January 15, 2004; 103(2): 656 - 663.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. T. Spiotto, M. A. Reth, and H. Schreiber
Genetic changes occurring in established tumors rapidly stimulate new antibody responses
PNAS, April 29, 2003; 100(9): 5425 - 5430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Milutinovic, Q. Zhuang, A. Niveleau, and M. Szyf
Epigenomic Stress Response. KNOCKDOWN OF DNA METHYLTRANSFERASE 1 TRIGGERS AN INTRA-S-PHASE ARREST OF DNA REPLICATION AND INDUCTION OF STRESS RESPONSE GENES
J. Biol. Chem., April 18, 2003; 278(17): 14985 - 14995.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-Y. Lee, Y. Obata, M. Yoshida, E. Stockert, B. Williamson, A. A. Jungbluth, Y.-T. Chen, L. J. Old, and M. J. Scanlan
Immunomic analysis of human sarcoma
PNAS, March 4, 2003; 100(5): 2651 - 2656.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-Y. Zhang, C. A. Casiano, X.-X. Peng, J. A. Koziol, E. K. L. Chan, and E. M. Tan
Enhancement of Antibody Detection in Cancer Using Panel of Recombinant Tumor-associated Antigens
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 136 - 143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.